Member Exclusive

Identifying ATM inhibitors for potential Huntington’s disease therapeutics: an interview with Perla Breccia

In this interview, Perla Breccia, Team Leader, Chemistry, Charles River (MA, USA), discusses her poster presented at the 19th RSC / SCI Medicinal Chemistry Symposium (10–13 September 2017, Churchill College, Cambridge, UK).

Go to the profile of Jasmine Harris
Oct 16, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.